Related Experiment Video

Updated: Aug 8, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

[Etiopathogenesis of atherosclerosis--a clinical problem that is still relevant]

Małgorzata Mizerska1, Jan Henryk Goch

  • 1Uniwersytet Medyczny w Lodzi, Klinika Kardiologii I Katedry Kardiologii i Kardiochirurgii, Szpital Kliniczny Nr 3, kierownik

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|May 20, 2006
PubMed

Insights

Atherosclerosis development involves classic risk factors and infectious-inflammatory agents impacting vascular endothelium. This study details how these factors cause endothelial dysfunction, leading to atheromatous plaque formation.

Area of Science:

  • Cardiovascular Pathology
  • Immunology
  • Endothelial Biology

Background:

  • Atherosclerosis is a complex pathological process influenced by numerous risk factors.
  • Classic risk factors include age, hypertension, dyslipidemia (LDL cholesterol), smoking, diabetes, and obesity.
  • Emerging evidence highlights the significant role of infectious-inflammatory factors in initiating atherosclerotic changes.

Discussion:

  • Vascular endothelium serves as a primary target for infectious-inflammatory agents.
  • Pathomechanisms involve the intricate interactions between various risk factors and the endothelium.
  • These interactions precipitate endothelial dysfunction, a key step in atherogenesis.

Key Insights:

  • Infectious-inflammatory factors significantly contribute to the onset and progression of atherosclerosis.
  • Endothelial dysfunction is a central mechanism linking risk factors to plaque development.
  • The interplay between different risk factors exacerbates atherosclerotic changes.

Outlook:

  • Further research into the specific infectious-inflammatory pathways is warranted.
  • Targeting endothelial dysfunction may offer novel therapeutic strategies for atherosclerosis.
  • Understanding these complex interactions is crucial for developing effective prevention and treatment approaches.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...